The 4Q11 & 2011 OnBioVC Trend Analysis study is available for download [HERE].

OnBioVC the industry leader in organizing and reporting life science private venture financings, today announced the release of its 2011 Trend Analysis. The 4Q11 OnBioVC Trend Analysis tracked, in aggregate, 93 biopharma, diagnostic, device, medical-IT and biofuel venture financings totaling $1,662.8M, compared to 4Q10 OnBioVC data, this investment activity represents an increase in the number of quarter-over-quarter financings by 37 (93 v. 56) and an increase in quarter-over-quarter total invested capital of $816.6M ($1,662.8M v. $846.2M). 2011 likewise yielded year-over-year increases v. 2010 in total deals (305 v. 281) and invested capital ($6,071.2 v. $5,190.5). 4Q11 also provided the largest number of Series A financings in fifteen quarters of OnBioVC data tracking, where 37 first-time institutional financings raised $483.4M.